Andrew Radonjic – Managing Director – Venture Minerals (ASX:VMS) is dedicated to discovering and developing world-class mineral deposits to meet global demand for critical minerals vital to the green energy transition.
Copyright 2024 – Finance News Network
Source: Finance News Network
12 Aug 2025 - CEO and Managing Director Mark Freeman and Portfolio Manager Brett McNeill discuss the FY25 full-year results of Djerriwarrh Investments (ASX:DJW).
Read More08 Mar 2024 - Dotz Nano's (ASX:DTZ) groundbreaking Dotz Earth Technology is revolutionizing carbon capture. CEO Sharon Malka shares insights on their recent bench-scale unit success and partnership with SINTEF, highlighting strides towards a carbon-neutral future
Read More21 Oct 2024 - Ken Morrison, CEO of the Bradfield Development Authority, discusses building Australia's first new city in a century, a high-tech urban project linked to the new Western Sydney International Airport.
Read More18 Jan 2021 - Tourism Accommodation Australia CEO Michael Johnson discusses the impact of COVID-19 on hotels across Australia.
Read More04 Dec 2019 - DigitalX Limited (ASX:DCC) Executive Director Leigh Travers talks about the growing interest in blockchain solutions for real world problems and the company's new DigitalX Bitcoin Fund.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More20 Mar 2023 - Beston Global Food Company Limited (ASX:BFC) CEO Fabrizio Jorge discusses half-year results, the impact of weather on milk supply, lactoferrin pricing, export markets, the recent capital raising, and M&A opportunities.
Read More16 Aug 2023 - Sam Budiselik - Managing Director - Cash Converters (ASX:CCV) is a diverse group generating revenues from franchising, store operations, personal and vehicle finance.
Read More05 Dec 2019 - Bio-Gene Technology Limited (ASX:BGT) CEO, Richard Jagger discusses the company's novel suite of insecticides, progress with trials and market opportunity.
Read More03 Dec 2019 - Noxopharm Limited (ASX:NOX) Executive Chairman & CEO, Dr Graham Kelly, discusses clinical results from the company's Phase 1b clinical DARRT-1 trial for its lead product candidate, Veyonda, with low-dose radiotherapy.
Read More
